The unique therapeutic indications for PQ and the absence of alternatives have made it indispensable in the treatment of P. vivax malaria, despite its known haemotoxicity in individuals with genetic deficiency in G6PD. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.